Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1766395

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1766395

STI and Vaginitis PCR Testing Market Size, Share, Trends, & Industry Analysis Report By Condition [Sexually Transmitted Infections (STIs) and Vaginal Infections], By Test Type, By End Use, and By Region - Market Forecast, 2025-2034

PUBLISHED:
PAGES: 125 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The global STI and vaginitis PCR testing market size is expected to reach USD 1,578.43 million by 2034, according to a new study by Polaris Market Research. The report "STI and Vaginitis PCR Testing Size, Share, Trends & Industry Analysis Report: By Condition [Sexually Transmitted Infections (STIs) and Vaginal Infections], By Test Type, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The STI and vaginitis PCR testing market focuses on the implementation of advanced diagnostics using polymerase chain reaction (PCR) technology for pathogen specific testing of STIs and different types of vaginal infections. These infections encompass common sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and trichomoniasis, alongside vaginal infections such as bacterial vaginosis and vulvovaginal candidiasis. PCR testing is unique among other testing methods due to its high sensitivity and specificity, and its ability to accurately capture the genetic material of causative organisms, no matter how minute the quantities are. This level of precision is essential for prompt and accurate diagnosis and an intense and precise treatment plan that addresses disease progression and further transmission needs.

The expectations related to this area of testing are particularly optimistic for multiple reasons. The rising prevalence of STIs and vaginitis regionally augments the demand for accurate diagnosis. The advancement in molecular diagnostic tools, as in the case of multiplex PCR assay development, is also accelerating growth in this area. The ability to detect multiple pathogens from a single sample increases both efficiency and provides enhanced diagnostic information for clinicians. Moreover, public awareness and proactive screening campaigns heighten population testing intensity, which is an encouraging trend directed toward explicitly defined sexual and reproductive health. Such changes necessitate accurate and reliable tools for diagnosis and, thereby, purposeful and strategic toward letter accessibility.

STI and Vaginitis PCR Testing Market Report Highlights:

By condition, the sexually transmitted infections (STIs) segment held a larger share in 2024, driven by the persistent high global prevalence of various STIs, many of which are asymptomatic, and the crucial need for accurate, sensitive diagnostic tools such as PCR for widespread screening and public health management.

By test type, the STI PCR panels segment dominated the market in 2024. The dominance is primarily attributed to the critical requirement for accurate and sensitive detection of a broad range of sexually transmitted pathogens, often simultaneously through multiplex panels, which are essential for comprehensive diagnosis and treatment guidance.

By end use, the diagnostic laboratories segment held the largest share in 2024, owing to their specialized infrastructure, high-throughput capabilities, and the expertise necessary for processing a large volume of complex molecular diagnostic tests from various healthcare settings.

By region, North America holds a substantial share of the STI and vaginitis PCR testing market. This is largely attributed to the robust healthcare infrastructure, high awareness regarding sexual health, and the early adoption of advanced diagnostic technologies, including PCR-based assays. The Asia Pacific STI and vaginitis PCR testing market is anticipated to exhibit a significant growth rate during the forecast period. This growth is primarily fueled by improving healthcare infrastructure, increasing disposable incomes, and a rising awareness about sexual and reproductive health in countries such as China and India.

A few key players in the market include Hologic, Inc.; BD (Becton, Dickinson and Company); bioMerieux; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Qiagen; OraSure Technologies; and SpeeDx Pty Ltd. Additionally, some key entities operate under larger parent organizations, such as Cepheid (Danaher) and Luminex Corporation (DiaSorin S.p.A.).

Polaris Market Research has segmented the STI and vaginitis PCR testing market report on the basis of condition, test type, end use, and region:

By Condition Outlook (Revenue - USD Million, 2020-2034)

Sexually Transmitted Infections (STIs)

Chlamydia

Gonorrhea

Trichomoniasis

Herpes Simplex Virus (HSV-1 & HSV-2)

Human Papillomavirus (HPV)

Syphilis

Other

Vaginal Infections

Bacterial Vaginosis

Vulvovaginal Candidiasis

Other

By Test Type Outlook (Revenue - USD Million, 2020-2034)

STI PCR Panels

Vaginitis PCR Panels

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals & Clinics

Diagnostic Laboratories

Homecare/At-home Testing

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM5767

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global STI and Vaginitis PCR Testing Market Insights

  • 4.1. STI and Vaginitis PCR Testing Market - Market Snapshot
  • 4.2. STI and Vaginitis PCR Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of STIs and Vaginitis
      • 4.2.1.2. Technological Advancements in Molecular Diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and infrastructure barriers
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. STI and Vaginitis PCR Testing Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global STI and Vaginitis PCR Testing Market, by Condition

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • 5.3. Sexually Transmitted Infections (STIs)
    • 5.3.1. Global STI and Vaginitis PCR Testing Market, by Sexually Transmitted Infections (STIs), by Region, 2020-2034 (USD Million)
    • 5.3.2. Chlamydia
    • 5.3.3. Gonorrhea
    • 5.3.4. Trichomoniasis
    • 5.3.5. Herpes Simplex Virus (HSV-1 & HSV-2)
    • 5.3.6. Human Papillomavirus (HPV)
    • 5.3.7. Syphilis
    • 5.3.8. Other
  • 5.4. Vaginal Infections
    • 5.4.1. Global STI and Vaginitis PCR Testing Market, by Vaginal Infections, by Region, 2020-2034 (USD Million)
    • 5.4.2. Bacterial Vaginosis
    • 5.4.3. Vulvovaginal Candidiasis
    • 5.4.4. Other

6. Global STI and Vaginitis PCR Testing Market, by Test Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • 6.3. STI PCR Panels
    • 6.3.1. Global STI and Vaginitis PCR Testing Market, by STI PCR Panels, by Region, 2020-2034 (USD Million)
  • 6.4. Vaginitis PCR Panels
    • 6.4.1. Global STI and Vaginitis PCR Testing Market, by Vaginitis PCR Panels, by Region, 2020-2034 (USD Million)

7. Global STI and Vaginitis PCR Testing Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Global STI and Vaginitis PCR Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Global STI and Vaginitis PCR Testing Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
  • 7.5. Homecare/At-home Testing
    • 7.5.1. Global STI and Vaginitis PCR Testing Market, by Homecare/At-home Testing, by Region, 2020-2034 (USD Million)
  • 7.6. Others
    • 7.6.1. Global STI and Vaginitis PCR Testing Market, by Others, by Region, 2020-2034 (USD Million)

8. Global STI and Vaginitis PCR Testing Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. STI and Vaginitis PCR Testing Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. STI and Vaginitis PCR Testing Market - North America
    • 8.3.1. North America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
    • 8.3.2. North America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
    • 8.3.3. North America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.3.4. STI and Vaginitis PCR Testing Market - U.S.
      • 8.3.4.1. U.S.: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.3.5. STI and Vaginitis PCR Testing Market - Canada
      • 8.3.5.1. Canada: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • 8.4. STI and Vaginitis PCR Testing Market - Europe
    • 8.4.1. Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
    • 8.4.2. Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
    • 8.4.3. Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.4. STI and Vaginitis PCR Testing Market - UK
      • 8.4.4.1. UK: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.4.2. UK: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.4.3. UK: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.5. STI and Vaginitis PCR Testing Market - France
      • 8.4.5.1. France: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.5.2. France: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.5.3. France: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.6. STI and Vaginitis PCR Testing Market - Germany
      • 8.4.6.1. Germany: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.7. STI and Vaginitis PCR Testing Market - Italy
      • 8.4.7.1. Italy: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.8. STI and Vaginitis PCR Testing Market - Spain
      • 8.4.8.1. Spain: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.9. STI and Vaginitis PCR Testing Market - Netherlands
      • 8.4.9.1. Netherlands: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.10. STI and Vaginitis PCR Testing Market - Russia
      • 8.4.10.1. Russia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.11. STI and Vaginitis PCR Testing Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • 8.5. STI and Vaginitis PCR Testing Market - Asia Pacific
    • 8.5.1. Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.4. STI and Vaginitis PCR Testing Market - China
      • 8.5.4.1. China: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.4.2. China: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.4.3. China: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.5. STI and Vaginitis PCR Testing Market - India
      • 8.5.5.1. India: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.5.2. India: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.5.3. India: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.6. STI and Vaginitis PCR Testing Market - Malaysia
      • 8.5.6.1. Malaysia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.7. STI and Vaginitis PCR Testing Market - Japan
      • 8.5.7.1. Japan: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.8. STI and Vaginitis PCR Testing Market - Indonesia
      • 8.5.8.1. Indonesia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.9. STI and Vaginitis PCR Testing Market - South Korea
      • 8.5.9.1. South Korea: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.10. STI and Vaginitis PCR Testing Market - Australia
      • 8.5.10.1. Australia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.11. STI and Vaginitis PCR Testing Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • 8.6. STI and Vaginitis PCR Testing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.6.4. STI and Vaginitis PCR Testing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.6.5. STI and Vaginitis PCR Testing Market - UAE
      • 8.6.5.1. UAE: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.6.6. STI and Vaginitis PCR Testing Market - Israel
      • 8.6.6.1. Israel: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.6.7. STI and Vaginitis PCR Testing Market - South Africa
      • 8.6.7.1. South Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.6.8. STI and Vaginitis PCR Testing Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • 8.7. STI and Vaginitis PCR Testing Market - Latin America
    • 8.7.1. Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
    • 8.7.2. Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
    • 8.7.3. Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.7.4. STI and Vaginitis PCR Testing Market - Mexico
      • 8.7.4.1. Mexico: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.7.5. STI and Vaginitis PCR Testing Market - Brazil
      • 8.7.5.1. Brazil: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.7.6. STI and Vaginitis PCR Testing Market - Argentina
      • 8.7.6.1. Argentina: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.7.7. STI and Vaginitis PCR Testing Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BD (Becton, Dickinson and Company)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. bioMerieux
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cepheid (Danaher)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hologic, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Luminex Corporation (DiaSorin S.p. A.)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. OraSure Technologies
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Qiagen
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. SpeeDx Pty Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Thermo Fisher Scientific Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
Product Code: PM5767

List of Tables:

  • Table 1 Global STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 2 Global STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 3 Global STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 4 North America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 5 North America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 6 North America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 7 U.S.: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 8 U.S.: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 9 U.S.: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 10 Canada: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 11 Canada: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 12 Canada: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 13 Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 14 Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 15 Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 16 UK: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 17 UK: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 18 UK: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 19 France: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 20 France: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 21 France: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 22 Germany: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 23 Germany: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 24 Germany: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 25 Italy: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 26 Italy: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 27 Italy: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 28 Spain: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 29 Spain: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 30 Spain: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 31 Netherlands: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 32 Netherlands: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 33 Netherlands: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 34 Russia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 35 Russia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 36 Russia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 43 China: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 44 China: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 45 China: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 46 India: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 47 India: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 48 India: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 49 Malaysia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 50 Malaysia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 51 Malaysia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 52 Japan: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 53 Japan: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 54 Japan: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 55 Indonesia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 56 Indonesia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 57 Indonesia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 58 South Korea: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 59 South Korea: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 60 South Korea: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 61 Australia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 62 Australia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 63 Australia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 73 UAE: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 74 UAE: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 75 UAE: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 76 Israel: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 77 Israel: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 78 Israel: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 79 South Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 80 South Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 81 South Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 85 Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 86 Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 87 Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 88 Mexico: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 89 Mexico: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 90 Mexico: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 91 Brazil: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 92 Brazil: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 93 Brazil: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 94 Argentina: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 95 Argentina: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 96 Argentina: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global STI and Vaginitis PCR Testing Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Condition
  • Figure 7. Global STI and Vaginitis PCR Testing Market, by Condition, 2024 & 2034 (USD Million)
  • Figure 8. Market by Test Type
  • Figure 9. Global STI and Vaginitis PCR Testing Market, by Test Type, 2024 & 2034 (USD Million)
  • Figure 10. Market by End Use
  • Figure 11. Global STI and Vaginitis PCR Testing Market, by End Use, 2024 & 2034 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!